Andere talen Thermo Fisher Scientific Inc.

Aandelen

TMO

US8835561023

Geavanceerde medische apparatuur & technologie

Beurs gesloten - Nyse Andere beurzen 22:00:02 03-12-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
534,42 ^USD	+0,84%		+4,18%	+0,68%

02/12	THERMO FISHER SCIENTIFIC INC. : Nephron Research past advies aan	ZM
21/11	THERMO FISHER SCIENTIFIC INC. : CMB International verhoogt van Verkopen naar Kopen	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases	18/11
"Cinco acciones a comprar tras la victoria de Donald Trump en Estados Unidos"	16/11
Thermo Fisher Scientific Authorizes $4 Billion Share Buyback	15/11
Thermo Fisher Board Approves New $4 Billion Stock Buyback	15/11
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases	15/11
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023.	15/11
Thermo Fisher Scientific Inc. announces an Equity Buyback for $4,000 million worth of its shares.	15/11
Thermo Fisher Scientific Inc.'s Equity Buyback announced on November 14, 2023, has expired with 5,523,139 shares, representing 1.43% for $3,000 million.	15/11
Thermo Fisher Scientific Inc. authorizes a Buyback Plan.	15/11
OncoHost Announces Executive Appointment of Ron Andrews	14/11
Mainz Biomed, Thermo Fisher Partner to Develop Colorectal Cancer Screening Test	12/11
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets	12/11
Mainz Biomed N.V. and Thermo Fisher Scientific Inc. Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets	12/11
Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024	11/11
Quidelortho Corporation Announces Executive Changes	08/11
Thermo Fisher Scientific Keeps Quarterly Dividend at $0.39/Share, Payable Jan. 15 to Holders on Dec. 13	07/11
Thermo Fisher Scientific Declares Quarterly Dividend	07/11
Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on January 15, 2025	07/11
Seer Enters into A Co-Marketing and Sales Agreement with Thermo Fisher Scientific	06/11
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023.	01/11
Thermo Fisher Scientific Insider Sold Shares Worth $11,049,123, According to a Recent SEC Filing	30/10
Devyser Diagnostics AB publishes quarterly report for the period July to September 2024	30/10
Thermo Fisher Scientific Insider Sold Shares Worth $1,120,320, According to a Recent SEC Filing	29/10
Devyser Enters Collaboration to Secure US Approval for Kidney Transplant Monitoring Test	29/10
Devyser seeks to secure FDA approval for NGS test for kidney transplant monitoring	29/10

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Headlines

Thermo Fisher Scientific: opent het bal in de biotech met veel grandeur

27 juli 2024 om 22:09 uur